Entry Point Capital, LLC Insmed Inc Transaction History
Entry Point Capital, LLC
- $171 Million
- Q3 2024
A detailed history of Entry Point Capital, LLC transactions in Insmed Inc stock. As of the latest transaction made, Entry Point Capital, LLC holds 5,563 shares of INSM stock, worth $387,240. This represents 0.24% of its overall portfolio holdings.
Number of Shares
5,563
Previous 1,004
454.08%
Holding current value
$387,240
Previous $67.3 Million
99.4%
% of portfolio
0.24%
Previous 0.1%
Shares
3 transactions
Others Institutions Holding INSM
# of Institutions
466Shares Held
180MCall Options Held
2.27MPut Options Held
3.33M-
Vanguard Group Inc Valley Forge, PA17.1MShares$1.19 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$993 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.6MShares$876 Million0.11% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y910.5MShares$731 Million62.32% of portfolio
-
Capital International Investors Los Angeles, CA6.52MShares$454 Million0.09% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $9.43B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...